Cytiva AKTA Process Chromatography System for Biopharmaceutical Scale-Up
Cytiva
Details
-
CategoryProcess / Scale-Up
-
Dimension38.0in x 72.0in x 65.0in
-
Serial29696975
-
Shipping TypeFreight
Description
The Cytiva AKTA Process Chromatography System is a sophisticated solution designed for process scale-up and large-scale biopharmaceutical manufacturing. Manufactured by Cytiva, this AKTA Process system features an automated liquid chromatography system ideal for transitioning processes developed on smaller AKTA models. Its flexible design supports over a million possible configurations, ensuring adaptability to various process demands. This system is compatible with the AxiChrom chromatography platform, enabling efficient column packing and unit operations. It includes a computer pre-installed with software for seamless operation. In excellent condition, this unit displays little to no cosmetic damage and functions as intended.
Key Features
- Automated liquid chromatography system
- Suitable for process scale-up
- Compatible with AxiChrom columns
- Flexible design with 1 million configurations
- Includes computer and software
Specifications
- Flow rate range: 1 L/h to 2000 L/h
- Material: Electropolished stainless steel or polypropylene piping
- Configuration: Over a million possibilities
- Calibration: Automatic UV-sensor, offline pH and conductivity sensor
- Compliance: GMP-regulated environment
Weight
Imperial: 1136.4 Pounds
Metric: 515.46 Kilograms
Shipping Dimensions
Imperial: 45.6 lb x 86.4 lb x 78.0 lb
Metric: 115.82 cm x 219.46 cm x 198.12 cm
Harmonized Code
9027.80.45
Harmonized Code Details
9027.80.45 refers to chemical analysis instruments. Suitable for the Cytiva AKTA Process due to its chromatographic analysis application within biopharmaceutical manufacturing.
Product Enquiry
Have a question about this product? Send us your enquiry and our sales team will get back to you shortly.
Product Make Offer
Submit your best offer for this product. Our sales team will review your request and connect with you as soon as possible.
Comments 0
There are currently no public comments.